SYNCROSOME - Cardiology Preclinical service
Preclinical in vivo studies
- B2B
About SYNCROSOME - Cardiology Preclinical service
A preclinical CRO specializing in in vivo efficacy studies for drug discovery companies, offering disease models, biomarkers, and tailored experimental protocols
Key facts
- Industry
- Research Services
- Company size
- 1–10 employees
- Headquarters
- Marseille, Provence-Alpes-Côte d'Azur, France
- Founded
- 2000
- Revenue
- $1.3M – $9MTamtam estimate
- Website
- etap-lab.com
SYNCROSOME - Cardiology Preclinical service at a glance
SYNCROSOME - Cardiology Preclinical service is a B2B company in the Research Services industry, headquartered in Marseille, Provence-Alpes-Côte d'Azur, France.
SYNCROSOME - Cardiology Preclinical service was founded in 2000.
SYNCROSOME - Cardiology Preclinical service has 1–10 employees.
SYNCROSOME - Cardiology Preclinical service's revenue is $1.3M – $9M (Tamtam estimate).
Selling to companies like SYNCROSOME - Cardiology Preclinical service?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies